New pill aims to tame chaotic heartbeats in atrial fibrillation
Disease control
Recruiting now
This Phase 2 trial tests whether the experimental drug AP31969 can reduce the amount of time people with atrial fibrillation spend in an irregular heart rhythm. Two hundred adults with paroxysmal or persistent AF will receive either AP31969 or a placebo twice daily for several we…
Phase: PHASE2 • Sponsor: Acesion Pharma • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC